Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
Dalong Zhu(Nanjing Drum Tower Hospital), Shenglian Gan(The First People's Hospital of Changde), Yu Liu(Second Affiliated Hospital of Jilin University), Jianhua Ma(Nanjing Medical University), Xiaolin Dong(Jinan Central Hospital), Weihong Song(Chenzhou First People's Hospital), Jiao’e Zeng(Sun Yat-sen University), Guixia Wang(Jilin University), Wenjuan Zhao(Qingdao University), Qiu Zhang(Anhui Medical University), Yukun Li(Hebei Medical University), Hui Fang(Tangshan Gongren Hospital), Xiaofeng Lv, Yongquan Shi(Shanghai Changzheng Hospital), Haoming Tian(Sichuan University), Linong Ji(Peking University), Xin Gao(Sun Yat-sen University), Lihui Zhang(Hebei Medical University), Yuqian Bao(Shanghai Jiao Tong University), Minxiang Lei(Central South University), Ling Li(China Medical University), Longyi Zeng(Sun Yat-sen University), Xiaoying Li(Sun Yat-sen University), Xinghua Hou(Hua Medicine (China)), Yu Zhao(Hua Medicine (China)), Tian‐Xin Hu(Hua Medicine (China)), Xiaoyun Ge(Hua Medicine (China)), Guiyu Zhao(Hua Medicine (China)), Yongguo Li(Hebei Medical University), Yi Zhang(Hua Medicine (China)), Li Chen(Hua Medicine (China))
Cited by 102
Abstract
Related Papers
No related papers found
Powered by citation graph analysis